This page includes Regulatory news filings supplied by issuers listed on the BSX. Please note the BSX is not responsible for the content, accuracy or completeness of announcements filed by issuers and disclaims all liability for any loss arising from reliance on information contained within issuer announcements.
Covidien Initiates Quarterly Cash Dividend
Pembroke, Bermuda: September 28, 2007 -- Covidien Ltd. (NYSE: COV; BSX: COV.BH) announced today that its Board of Directors has declared a quarterly cash dividend of $0.16 per common share. The dividend is payable on November 9, 2007 to shareholders of record on October 9, 2007.
"This declaration, our first dividend as a public company, is an important milestone for the Company and its investors," said President and Chief Executive Officer Richard J. Meelia.
ABOUT COVIDIEN LTD.
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines, including Surgical Devices, Energy-based Devices, Respiratory and Monitoring Solutions, Patient Care and Safety Products, Imaging Solutions, Pharmaceutical Products, Medical Supplies and Retail Products. With 2006 revenue of nearly $10 billion, Covidien has more than 43,000 employees worldwide in 57 countries, and its products are sold in over 130 countries. For additional information, please visit our website, www.covidien.com.
CONTACTS:
Eric Kraus Coleman Lannum, CFA
Senior Vice President Vice President
Corporate Communications Investor Relations
508-261-8305 508-452-4343
eric.kraus@covidien.com cole.lannum@covidien.com
Bruce Farmer Wayde McMillan
Director Director
Financial Communications Investor Relations
508-452-4372 508-452-4387
bruce.farmer@covidien.com wayde.mcmillan@covidien.com